UK / Private Equity
Ian joined 3i in 1987 and became a Partner in 1994 prior to its IPO on the London Stock Exchange. Currently based in London, having previously been based in Paris, he is an experienced investor and Board member across three continents, business types and sectors including Industrials, Healthcare and Business & Technology Services.
In his current role as Managing Partner, Asset Management, Ian is involved in investing and asset management activity across 3i Private Equity and Infrastructure.
His current board focus is on a number of leading, international companies including: AESSEAL (seals for rotating equipment), Cirtec Medical (medical device outsourcing), Tato (specialty chemicals) and ACR Capital Holdings (pan-Asian reinsurance). Ian is also a Director of 3i Infrastructure plc, the FTSE250 listed long-term investor in infrastructure businesses and assets, and BSI Group, the global standards and services company driving company excellence and resilience.
Prior to his current role, Ian led 3i’s Technology business in Europe having invested in areas including security software (Sophos), artificial intelligence (Searchspace), mobile technology (Nujira) and genomics (Oxagen).
Ian is a member of the 3i Group Investment Committee and the BVCA UK and European Capital Committee.
Ian graduated in Chemical Engineering from the University of Birmingham. Prior to 3i, Ian worked as an Engineer for BOC Specialty Gases in the UK supplying the medical, semi-conductor and space research sectors.